FOURKITES
16.6.2022 10:25:04 CEST | Business Wire | Press release
Leading real-time supply chain visibility platform FourKites® today announces it has outpaced its annual growth targets in the European, Middle Eastern and African (EMEA) markets. The company achieved 148% growth in shipments over the last 12 months, exceeding its target projections of 100% growth. The number of customers tracking loads with FourKites in EMEA has grown by 59% in the last 12 months, while the number of carriers tracking shipments has grown by 55% in the same period.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220616005418/en/
“Over the last year, we’ve invested heavily in Europe — in our team, our partners, our products and our customers. Today’s complex supply chains require global, end-to-end visibility, and the region is vital to global trade,” says FourKites CEO and founder, Mathew Elenjickal. “We’re seeing that investment reflected by our accelerated growth metrics over the last year.”
Some of FourKites’ most recent customer additions include Barilla Group, Beyond Meat, Cardinal Health, Haworth, LyondellBasell, McCain Foods, Roehm, Rove Concepts and Yamaha Motors.
Local investment pays off
In January 2022, FourKites acquired German supply chain visibility provider NIC-place , the market leader in supply chain visibility software solutions specifically designed for transport companies, carriers and logistics service providers. The acquisition created the largest multimodal carrier network in Europe, serving global shippers with the most comprehensive end-to-end global supply chain visibility platform.
In addition, over the last few months, FourKites has been investing in its local teams with seasoned industry veterans to build the infrastructure needed to support its growing European network. Recent senior-level hires include Katja van Trigt, Senior Director Talent & Development EMEA, who comes to FourKites with an enviable record having worked at American Express, Bausch & Lomb and Infoblox.
Jeroen Peijnenburg, Enterprise Account Director, Southern Europe, will lead FourKites’ supply chain visibility operations across the region. He has worked for many years in leadership positions within global, asset-owning carriers and logistics service providers.
Nicu Ciontea, Carrier Manager, based in Amsterdam, will increase carrier support across Europe. Until recently, Nicu led the carrier sales team at CH Robinson in Amsterdam.
Nicholas Mellings, Enterprise Account Director EMEA will lead FourKites’ UK Sales team. Nicholas brings with him 30 years of experience in the transport and logistics industry, the last five of which were spent working for Transporeon.
New offices
FourKites has also been growing its European presence with new offices. The company has opened a larger European headquarters in Amsterdam; a new office in Munich serving the pivotal German market; and an increased presence in Poland to serve the Eastern European carrier market.
“To support our growing network of European shippers and carriers, we have taken the steps necessary to ensure that we have a strong local presence, with highly specialised knowledge of the European market,” says Elenjickal. Elenjickal himself is currently touring in Europe, visiting the new offices, meeting face to face with customers, and personally welcoming FourKites’ new supply chain experts brought onboard to fuel organic growth.
“Europe is rapidly seizing the benefits of supply chain visibility,” he adds. “European businesses are finding that FourKites’ approach is a natural fit with their current needs, and that synergy is what’s creating more transparency, collaboration and resilience in global supply chains.”
“Digitisation is an important step in Dow’s journey toward the implementation of an end-to-end supply chain visibility strategy,” says Kevin Nielen, Logistics Leader, Dow Chemical. “Our strategic partnership with FourKites enables us to digitise and move away from a manual way of working to an integrated technology platform workflow.”
FourKites Europe in numbers
Top five countries by load volume: Belgium, France, Germany, Netherlands and Italy.
148% growth in EMEA shipments over the last 12 months
59% growth in the number of customers tracking loads in EMEA over the last 12 months
55% growth in the number of carriers tracking shipments in EMEA over the last 12 months
2.4 billion km tracked in EMEA in the last 12 months
Ports: Over the last 12 months, FourKites saw a 15% growth in the number of ports tracked in EMEA. We now cover 295 ports in the region.
Over the last 12 months, FourKites saw a 92% growth in the number of facilities tracked in EMEA. We now cover 134,000 facilities in the region.
About FourKites
Leading global supply chain visibility platform FourKites® extends visibility beyond transportation into yards, warehouses, stores and beyond. Tracking more than 2.5 million shipments daily across road, rail, ocean, air, parcel and courier, and reaching more than 200 countries, FourKites combines real-time data and powerful machine learning to help companies digitise their end-to-end supply chains. More than 1,000 of the world’s most recognised brands — including 9 of the top-10 CPG and 18 of the top-20 food and beverage companies — trust FourKites to transform their business and create more agile, efficient and sustainable supply chains. To learn more, visit https://www.fourkites.com/ .
View source version on businesswire.com: https://www.businesswire.com/news/home/20220616005418/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
IEO and Laife Reply Join Forces to Digitalise the Biobank Through Artificial Intelligence10.2.2026 10:00:00 CET | Press release
The two partners launch “Bianca”, the first large-scale digitalisation initiative in Italy focused on histopathological samples, aimed at training AI algorithms to support pathologists’ diagnostic activities. The Pathology Division of the European Institute of Oncology (IEO) and Laife Reply, the Reply Group company specialised in AI and Big Data solutions for the healthcare sector, have entered into a collaboration to develop Bianca, the first project in Italy aimed at creating an AI-based digital biobank designed as an integral part of clinical diagnostic practice. The initiative is part of a broader technological innovation journey that structurally integrates research and development into routine diagnostic processes in pathology, transforming the traditional histopathological sample workflow into an end-to-end digital ecosystem. The complete digitalisation of histopathological and molecular diagnostic workflows aims to make analysis more efficient, scalable and reproducible, laying
OPEX® Corporation Introduces the Velo™ Series of Premium Desktop and High Production Document Scanners10.2.2026 10:00:00 CET | Press release
OPEX® Corporation, a global leader in Next Generation Automation providing innovative solutions for warehouse, document and mail automation, has announced the launch of its Velo™ Series powered by InoTec, a new class of premium desktop and free standing high production scanners. The OPEX Velo scanners are engineered to deliver exceptional performance, reliability and image quality and offer industry-standard TWAIN/ISIS connectivity to help simplify deployment into existing capture environments. These state-of-the-art scanners are ideal for service bureaus, government agencies, healthcare providers and enterprise capture operations. “The Velo Series powered by InoTec introduces an entirely new class of scanners to the OPEX portfolio, expanding the options available to both our current customers and organizations considering OPEX for the first time,” said Dann Worrell, President, Document and Mail Automation, OPEX. “By broadening our offerings, we can better align the right solution with
New ZOLL Zenix Monitor/Defibrillator Receives MDR Approval10.2.2026 10:00:00 CET | Press release
ZOLL®, an Asahi Kasei company that manufactures medical devices and related software solutions, announced today that Zenix®, the company’s most clinically advanced and easy-to-use professional monitor/defibrillator, is approved under the European Union (EU) Medical Device Regulation 2017/745, commonly referred to as EU MDR. The Zenix monitor/defibrillator is a groundbreaking device that redefines efficiency, clarity, and intelligence in both EMS and hospital settings. Built from years of feedback from customers, Zenix combines intuitive design with powerful functionality to enhance patient care and automate workflows for ease-of-use. Featuring a large, durable touchscreen, Zenix provides critical information when it’s needed. With on-the-fly customization, healthcare professionals can make real-time adjustments, helping them stay in control during high-pressure situations. Equipped with ZOLL’s innovative Real BVM Help® and exclusive Real CPR Help® technology, Zenix gives healthcare pro
Expereo Elevates expereoOne with New Digital Case Management Capabilities, Delivering Faster, Clearer and More Predictable Service Resolution10.2.2026 10:00:00 CET | Press release
Expereo is redefining what’s possible for global enterprises at CiscoLive Amsterdam with the launch of its enhanced Digital Case Management (DCM) capability in expereoOne. As the world-leading managed Network as a Service (NaaS) provider, Expereo is putting customers firmly in control - slashing resolution times, cutting through operational noise and ensuring everyone is aligned every step of the way. With DCM, service issues are no longer bottlenecks: instead, enterprises experience swift, transparent outcomes, with every stakeholder empowered through a single, real-time view of progress. DCM is designed around a simple objective: enable enterprises to resolve issues faster, with greater clarity and full control, through a fully digital, software-first workflow inside expereoOne. Customers can create, manage and track cases end-to-end within a single platform, ensuring predictable, consistent and aligned service experiences across their global network footprint. Unified, digital-first
U.S. Food and Drug Administration Accepts New Drug Application and Grants Priority Review for Takeda’s Oveporexton (TAK-861) as a Potential First-in-Class Therapy for Narcolepsy Type 110.2.2026 09:15:00 CET | Press release
This FDA Acceptance is a Milestone for People Living with Narcolepsy Type 1 Who Need New and Different Treatment OptionsOveporexton is an Orexin Agonist Designed to Restore Orexin Signaling and Address the Underlying Orexin Deficiency that Causes Narcolepsy Type 1The Prescription Drug User Fee Act (PDUFA) Target Action Date is the Third Quarter of this Calendar Year Takeda (TSE:4502/NYSE:TAK) today announced that the U.S. Food and Drug Administration (FDA) accepted its New Drug Application (NDA) and granted Priority Review for oveporexton (TAK-861) for the treatment of narcolepsy type 1 (NT1). Oveporexton is an investigational oral orexin receptor 2 (OX2R)-selective agonist designed to address the underlying orexin deficiency that causes NT1 by restoring orexin signaling. The FDA has set a Prescription Drug User Fee Act (PDUFA) goal date in the third quarter of this calendar year. Takeda remains on track to potentially bring the first approved orexin agonist treatment to people living
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
